Full text is available at the source.
Abstract
A total of 11,744 participants were integrated from five cohorts to analyze genetic determinants of the biomarker 6-sulfatoxymelatonin (aMT6s).
- No genome-wide significant genetic loci for aMT6s were identified in the multi-ancestry analysis.
- Twenty-three loci emerged at suggestive significance, with eight supported by multiple analytical methods.
- Two loci displayed ancestry-specific genetic differences, indicating the influence of population context on aMT6s genetics.
- Polygenic risk scores showed strong associations with type 2 diabetes and sleep duration, suggesting links between aMT6s genetics and metabolic traits.
- Findings emphasize the importance of considering ancestry when interpreting genetic data related to melatonin metabolism.
Simplified